Ind-Swift Laboratories share news and announcements
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.
52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,848 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 49.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 41.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,58,24852.8% delivered
Ind-Swift Laboratories routine notices
100 filed, newest first. Page 2 of 2.
Jun 2023
May 2023
Apr 2023
29 Apr · Routine
Mar 2023
Feb 2023
10 Feb · Routine
Jan 2023
Dec 2022
Nov 2022
10 Nov · Routine
Sep 2022
29 Sep · Routine
2 Sep · Routine
Jun 2022
29 Jun · Routine
Mar 2022
30 Mar · Routine
Jan 2022
Dec 2021
Nov 2021
Oct 2021
Sep 2021
Aug 2021
Jul 2021
Jun 2021
Mar 2021
Feb 2021
Dec 2020
Nov 2020
Oct 2020
Sep 2020
7 Sep · Routine
Jul 2020
7 Jul · Routine
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Feb 2019
Nov 2018
May 2018
Jan 2018
May 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Feb 2015
Jan 2015
Oct 2014
28 Oct · Routine
As per the Company's Code of Conduct for prevention of Insider Trading read with SEBI (Prohibition of Insider Trading) Regulation, 1992, the Trading Window for dealing in Equity Shares of the Company shall remain closed from October 28, 2014 to November 08, 2014 (both days inclusive) for the purpose of declaration of Unaudited Financial Results for the quarter ended September 30, 2014. The "Trading Window" shall reopen for dealing in the equity shares of the Company from the start of business hours on November 09, 2014.